Webinars

Webbsänd telefonkonferens: Immunovia reports historical breakthrough in early detection of pancreatic cancer in high risk groups

Tisdagen den 30 mars 2021, kl 16:30 CET

Presentationer av: Patrik Dahlen, CEO, Thomas King, MD, PhD, Linda Mellby, PhD, Immunovia

Immunovia reports positive results of the blinded clinical validation of IMMray® PanCan-d blood test for Stage I/II pancreatic cancers in familial/hereditary risk groups in USA – and improved test performance in detecting early stage pancreatic cancer in high risk symptomatic patients.

Immunovia’s IMMray® PanCan-d Webinar Series

Torsdagen den 17 december 2020 kl. 15:00 CET

Webinar nr. 3: IMMray® PanCan-d Verification study and Clinical Use

Presentationer av: Thomas King, MD, PhD, Linda Mellby, PhD, Laura Chirica, PhD, Immunovia

Moderator: Patrik Dahlen, CEO Immunovia

Immunovia interview with Prof. Stephen Pereira, Gastroenterologist and Hepatologist, BSc, PhD, FRCP, FRCPE, at the London Clinic (UCL), Principle Investigator for Immunovia´s PanSYM study in London, UK, in regard to the clinical utility of diagnostic tests in pancreatic cancer, December 8, 2020.

Onsdagen den 2 september 2020 kl. 16:00 CET

Webinar nr 2: Commercial Test Model Study & uppdatering av lanseringsaktiviteter

Presentatörer: Linda Mellby, PhD; Laura Chirica, PhD, samt Thomas King, MD, PhD

Immunovia’s Virtual Investor Day, tisdagen den 30 juni 2020

Online-mötet innehåller presentationer av Immunovias Styrelseordförande Carl Borrebaeck, VD Mats Grahn, Chief Commercial Officer Laura Chirica, Senior VP Sales North America Michael Pettigrew, samt Dr. Thomas King, Medical Director, följt av en frågestund.

Immunovia Presentation  – PDF version

Måndagen den 9 september 2019 kl. 18:30 CET

Webinar nr 1: Differentiating Pancreatic Ductal Adenocarcinoma (PDAC) from individuals with symptoms suggestive of PDAC, including type II diabetes, with ROC AUC values above 0.95

Presentatörer: Linda Mellby, PhD och Thomas King, Medical Director, PhD, Immunovia